PT99569A - Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contem - Google Patents
Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contemInfo
- Publication number
- PT99569A PT99569A PT99569A PT9956991A PT99569A PT 99569 A PT99569 A PT 99569A PT 99569 A PT99569 A PT 99569A PT 9956991 A PT9956991 A PT 9956991A PT 99569 A PT99569 A PT 99569A
- Authority
- PT
- Portugal
- Prior art keywords
- image
- eritromycin
- derivatives
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9014499A FR2669337B1 (fr) | 1990-11-21 | 1990-11-21 | Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments. |
FR9106333A FR2677025B1 (fr) | 1991-05-27 | 1991-05-27 | Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments. |
FR9110728A FR2680790B1 (fr) | 1991-08-29 | 1991-08-29 | Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments. |
Publications (2)
Publication Number | Publication Date |
---|---|
PT99569A true PT99569A (pt) | 1992-10-30 |
PT99569B PT99569B (pt) | 1999-04-30 |
Family
ID=27252354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99569A PT99569B (pt) | 1990-11-21 | 1991-11-21 | Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contem |
Country Status (26)
Country | Link |
---|---|
US (3) | US5444051A (pt) |
EP (1) | EP0487411B1 (pt) |
JP (1) | JP3130097B2 (pt) |
KR (1) | KR100189597B1 (pt) |
CN (1) | CN1033974C (pt) |
AT (1) | ATE133683T1 (pt) |
AU (1) | AU640290B2 (pt) |
BR (1) | BR9105062A (pt) |
CA (1) | CA2055912C (pt) |
CZ (1) | CZ290651B6 (pt) |
DE (1) | DE69116815T2 (pt) |
DK (1) | DK0487411T3 (pt) |
ES (1) | ES2082952T3 (pt) |
FI (1) | FI102281B (pt) |
GR (1) | GR3018848T3 (pt) |
HU (1) | HU218787B (pt) |
IE (1) | IE74713B1 (pt) |
IL (3) | IL99995A (pt) |
MA (1) | MA22344A1 (pt) |
MX (1) | MX9102159A (pt) |
NZ (1) | NZ240684A (pt) |
OA (1) | OA09523A (pt) |
PL (2) | PL169422B1 (pt) |
PT (1) | PT99569B (pt) |
RU (1) | RU2100367C1 (pt) |
SK (1) | SK281550B6 (pt) |
Families Citing this family (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
US5523399A (en) * | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
US5631355A (en) * | 1992-04-22 | 1997-05-20 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide a derivatives |
FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2707088B1 (fr) * | 1993-07-02 | 1995-08-25 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
CA2154550A1 (en) * | 1993-01-26 | 1994-08-04 | Yoko Misawa | 5-o-desosaminylerythronolide derivatives |
FR2702480B1 (fr) * | 1993-03-09 | 1995-04-28 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2713226B1 (fr) * | 1993-12-03 | 1996-01-05 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
IT1276901B1 (it) * | 1994-12-13 | 1997-11-03 | Zambon Spa | Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica |
FR2732684B1 (fr) * | 1995-04-06 | 1997-04-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
PT874863E (pt) * | 1995-11-08 | 2003-06-30 | Abbott Lab | Derivados 3-desoxi-3-descladinose de eritromicinasa e b |
US5747466A (en) * | 1995-11-08 | 1998-05-05 | Abbott Laboratories | 3-deoxy-3-descladinose derivatives of erythromycins A and B |
FR2742757B1 (fr) * | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
USRE38520E1 (en) * | 1996-02-28 | 2004-05-18 | Aventis Pharma S.A. | Erythromycin derivatives, method for preparing same, and use thereof as drugs |
FR2745290B1 (fr) * | 1996-02-28 | 1998-04-03 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
US5750510A (en) * | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
CZ349698A3 (cs) * | 1996-05-07 | 1999-04-14 | Abbott Laboratories | 3-deskladinoso-2,3-anhydroerythromycinové deriváty |
EP0918783A1 (en) * | 1996-05-07 | 1999-06-02 | Abbott Laboratories | 6-o-substituted erythromycins and method for making them |
FR2751656B1 (fr) * | 1996-07-24 | 1998-10-16 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
CN100441591C (zh) * | 1996-09-04 | 2008-12-10 | 艾博特公司 | 酮基内酯类化合物,其用途和制备方法以及药用组合物 |
UA51730C2 (uk) * | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
US5804565A (en) * | 1996-09-24 | 1998-09-08 | Taisho Pharmaceutical Co., Ltd. | Erythromycin A derivatives |
FR2754821B1 (fr) * | 1996-10-23 | 2003-04-04 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2757168B1 (fr) * | 1996-12-12 | 1999-06-11 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2757518B1 (fr) * | 1996-12-23 | 1999-06-11 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2760017B1 (fr) * | 1997-02-27 | 1999-04-30 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments |
AU4472897A (en) * | 1997-03-10 | 1998-09-29 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
AU6421398A (en) * | 1997-03-24 | 1998-10-20 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
US5922683A (en) * | 1997-05-29 | 1999-07-13 | Abbott Laboratories | Multicyclic erythromycin derivatives |
JP2000513026A (ja) * | 1997-06-11 | 2000-10-03 | ファイザー・プロダクツ・インク | 9−オキシム エリスロマイシン誘導体 |
ZA987689B (en) * | 1997-09-02 | 1999-02-24 | Abbott Lab | 3-descladinose 6-O substituted erythromycin derivatives |
US6034069A (en) * | 1997-09-30 | 2000-03-07 | Abbott Laboratories | 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity |
PT1025114E (pt) * | 1997-09-30 | 2004-07-30 | Abbott Lab | Derivados de eritromicina-cetolido 6-o-substituido 3'-n-modificados possuindo actividade antibacteriana |
HN1998000159A (es) * | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
US6046171A (en) * | 1997-10-29 | 2000-04-04 | Abbott Laboratories | 6,11-bridged erythromycin derivatives |
CO4990960A1 (es) * | 1997-10-29 | 2000-12-26 | Abbott Lab | Derivados de cetolidos 2-halo-6-o sustituidos |
US6124269A (en) * | 1997-10-29 | 2000-09-26 | Abbott Laboratories | 2-Halo-6-O-substituted ketolide derivatives |
WO1999021868A1 (fr) | 1997-10-29 | 1999-05-06 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
CN1284961A (zh) * | 1997-12-11 | 2001-02-21 | 北陆制药株式会社 | 红霉素衍生物 |
AP1060A (en) * | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
US5972898A (en) * | 1998-03-27 | 1999-10-26 | Abbott Laboratories | 3',3-N-bis-substituted macrolide LHRH antagonists |
US5955440A (en) * | 1998-03-27 | 1999-09-21 | Abbott Laboratories | Macrolide LHRH antagonists |
HRP980189B1 (en) * | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
FR2777282B1 (fr) * | 1998-04-08 | 2001-04-20 | Hoechst Marion Roussel Inc | Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments |
FR2780977B1 (fr) * | 1998-07-09 | 2000-09-01 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
JP4573925B2 (ja) * | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
FR2781484B1 (fr) * | 1998-07-21 | 2001-08-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
IT1301967B1 (it) * | 1998-07-30 | 2000-07-20 | Zambon Spa | Derivato di eritromicina ad attivita' antibiotica |
US6020521A (en) * | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
US6387885B1 (en) * | 1998-08-26 | 2002-05-14 | Abbott Laboratories | 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
ES2243066T3 (es) | 1998-09-22 | 2005-11-16 | Pfizer Products Inc. | Antibioticos de carbamato y carbazato cetolida. |
FR2784682B1 (fr) * | 1998-10-15 | 2002-12-06 | Hoechst Marion Roussel Inc | Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments |
USRE39743E1 (en) * | 1998-10-15 | 2007-07-24 | Aventis Pharma S.A. | 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use |
FR2785612A1 (fr) * | 1998-11-10 | 2000-05-12 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
KR20010083944A (ko) * | 1998-11-03 | 2001-09-03 | 실버스타인 아써 에이. | 신규 마크롤라이드 항생물질 |
EP1137654A1 (en) | 1998-12-10 | 2001-10-04 | Pfizer Products Inc. | Carbamate and carbazate ketolide antibiotics |
SI1147121T1 (en) | 1999-01-27 | 2004-04-30 | Pfizer Products Inc. | Ketolide antibiotics |
KR100390159B1 (ko) * | 1999-03-09 | 2003-07-04 | (주)니드켐 | 불소를 함유한 산업폐수 처리제 및 처리방법 |
US6054435A (en) * | 1999-03-19 | 2000-04-25 | Abbott Laboratories | 6-O-substituted macrolides having antibacterial activity |
MXPA01010524A (es) * | 1999-04-16 | 2002-03-14 | Kosan Biosciences Inc | Agentes macrolidos anti-infecciosos. |
US6399582B1 (en) | 1999-04-16 | 2002-06-04 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
US6590083B1 (en) | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
US6939861B2 (en) * | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
US6514944B2 (en) | 1999-04-16 | 2003-02-04 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
HRP990116B1 (en) * | 1999-04-20 | 2007-10-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | NOVEL 8a AND 9a- 15-MEMBERED LACTAMES |
US6355620B1 (en) * | 1999-05-14 | 2002-03-12 | Abbott Laboratories | C-2 modified erythromycin derivatives |
EE200100613A (et) * | 1999-05-24 | 2003-02-17 | Pfizer Products Inc. | 13-metüülerütromütsiini derivaadid |
JP2003501439A (ja) * | 1999-06-07 | 2003-01-14 | アボット・ラボラトリーズ | 6−o−カルバメートケトライド誘導体 |
US6420535B1 (en) | 1999-06-07 | 2002-07-16 | Abbott Laboratories | 6-O-carbamate ketolide derivatives |
US6569836B2 (en) | 1999-12-02 | 2003-05-27 | Abbott Laboratories | 6-O-alkyl-2-nor-2-substituted ketolide derivatives |
US6946446B2 (en) | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
EP1259923B1 (en) * | 2000-02-24 | 2005-12-14 | Abbott Laboratories | Anti-infective agents useful against mulitidrug-resistant strains of bacteria |
JP2001261694A (ja) * | 2000-03-06 | 2001-09-26 | Pfizer Prod Inc | ケトライド抗生物質 |
EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
US6472372B1 (en) * | 2000-12-06 | 2002-10-29 | Ortho-Mcneil Pharmaceuticals, Inc. | 6-O-Carbamoyl ketolide antibacterials |
US20020132782A1 (en) * | 2001-01-18 | 2002-09-19 | Zhenkun Ma | 9-amino erythromycin derivatives with antibacterial activity |
EP1430068A1 (en) | 2001-09-17 | 2004-06-23 | Ortho-Mcneil Pharmaceutical, Inc. | 6-o-carbamate-11,12-lacto-ketolide antimicrobials |
US8425892B2 (en) | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
PL370714A1 (en) | 2001-12-05 | 2005-05-30 | Ortho-Mcneil Pharmaceutical, Inc. | 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials |
US6841664B2 (en) | 2002-07-25 | 2005-01-11 | Enanra Pharmaceuticals, Inc. | 6,11-4-carbon bridged ketolides |
WO2005070918A1 (en) * | 2002-05-13 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | Process for the preparation of t-11 bicyclic erythromycin derivatives |
US7910558B2 (en) * | 2002-05-13 | 2011-03-22 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
US7064110B2 (en) * | 2002-05-13 | 2006-06-20 | Enanta Pharmaceuticals, Inc. | 6-11 bicycle ketolide derivatives |
US6764998B1 (en) | 2003-06-18 | 2004-07-20 | Enanta Pharmaceuticals, Inc. | 6,11-4C-bicyclic 9a-azalide derivatives |
US7135573B2 (en) * | 2002-05-13 | 2006-11-14 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine |
US6753318B1 (en) | 2002-07-25 | 2004-06-22 | Enanta Pharmaceuticals, Inc. | 6,11-4-carbon bridged erythromycin derivatives |
US7273853B2 (en) * | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
US6878691B2 (en) * | 2002-05-13 | 2005-04-12 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
JP2005536465A (ja) * | 2002-05-13 | 2005-12-02 | エナンタ ファーマシューティカルズ インコーポレイテッド | 6,11二環式エリスロマイシン誘導体 |
AU2003234650A1 (en) | 2002-05-31 | 2003-12-19 | Janssen Pharmaceutica N.V. | 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents |
US6750204B2 (en) * | 2002-06-25 | 2004-06-15 | Enanta Pharmaceuticals, Inc. | 11-C-substituted ketolides |
US6812216B2 (en) * | 2002-06-25 | 2004-11-02 | Enanta Pharmaceuticals, Inc. | 11-C-substituted derivatives of clarithromycin |
ITMI20021726A1 (it) * | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
US7091196B2 (en) * | 2002-09-26 | 2006-08-15 | Rib-X Pharmaceuticals, Inc. | Bifunctional heterocyclic compounds and methods of making and using same |
EP2772254A3 (en) | 2003-03-10 | 2015-03-11 | Optimer Pharmaceuticals, Inc. | Novel Antibacterial Agents |
US6645941B1 (en) | 2003-03-26 | 2003-11-11 | Enanta Pharmaceuticals, Inc. | 6,11-3C-bicyclic 9a-azalide derivatives |
US20050101548A1 (en) * | 2003-09-12 | 2005-05-12 | Xiaodong Lin | Antimicrobial derivatives |
US7276487B2 (en) * | 2003-09-23 | 2007-10-02 | Enanta Pharmaceuticals, Inc. | 9a, 11-3C-bicyclic 9a-azalide derivatives |
WO2005030786A1 (en) * | 2003-09-25 | 2005-04-07 | Ranbaxy Laboratories Limited | 3'-n-substituted-3-o-substituted erythronolide a derivatives |
US20070149463A1 (en) * | 2003-10-30 | 2007-06-28 | Oyelere Adegboyega K | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
JP2007512256A (ja) * | 2003-11-18 | 2007-05-17 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法 |
US6953782B2 (en) * | 2003-12-24 | 2005-10-11 | Enanta Pharmaceuticals, Inc. | 11-C-substituted erythromycin derivatives |
WO2005067564A2 (en) * | 2004-01-07 | 2005-07-28 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic erythromycin derivatives |
WO2005070113A2 (en) * | 2004-01-09 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | 9n-substituted 6-11 bicyclic erythromycin derivatives |
JP4737495B2 (ja) * | 2004-01-14 | 2011-08-03 | 塩野義製薬株式会社 | エリスロマイシン誘導体 |
CN102816194A (zh) * | 2004-02-27 | 2012-12-12 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
ES2294733T3 (es) * | 2004-04-28 | 2008-04-01 | Alembic Limited | Proceso para la preparacion de telitromicina. |
US20080207536A1 (en) * | 2004-07-28 | 2008-08-28 | Ranbaxy Laboratories Limited | Antibacterial Agents |
ATE419261T1 (de) * | 2005-01-13 | 2009-01-15 | Glaxosmithkline Zagreb | Decladinosyl-macrolide mit entzündungshemmender wirkung |
US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
US7582611B2 (en) * | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
EP1907392A1 (en) * | 2005-07-26 | 2008-04-09 | Merckle Gmbh | Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
BRPI0619556A2 (pt) * | 2005-12-08 | 2011-10-04 | Pfizer | processo para desmetilação de grupo 3' -dimetil amino de compostos eritromicina |
RU2422453C2 (ru) * | 2006-12-05 | 2011-06-27 | Пфайзер Инк. | Полиморфы мотилида |
JP2010535776A (ja) * | 2007-08-10 | 2010-11-25 | ワイズセラピューティックス株式会社 | ロキシスロマイシン又はその誘導体の投与による免疫応答の調節 |
US8354383B2 (en) * | 2007-09-17 | 2013-01-15 | Enanta Pharmaceuticals, Inc. | 6,11-bridged biaryl macrolides |
JP5642548B2 (ja) * | 2007-09-17 | 2014-12-17 | エナンタ ファーマシューティカルズ インコーポレイテッド | 6,11−架橋ビアリールマクロライド |
US8273720B2 (en) * | 2007-09-17 | 2012-09-25 | Enanta Pharmaceuticals, Inc. | 6,11-bicyclolides: bridged biaryl macrolide derivatives |
JP5698979B2 (ja) * | 2007-10-25 | 2015-04-08 | センプラ ファーマシューティカルズ,インコーポレイテッド | マクロライド系抗菌剤の調製プロセス |
KR101026715B1 (ko) * | 2008-04-17 | 2011-04-14 | 한수케미칼 주식회사 | 불소이온 및 시안착화합물과 유리시안 제거제 및 이를이용한 폐수 처리방법 |
TW200946109A (en) | 2008-05-09 | 2009-11-16 | Enanta Pharm Inc | Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides |
CN105616437A (zh) * | 2008-10-24 | 2016-06-01 | 森普拉制药公司 | 使用含三唑的大环内酯的生物防御 |
US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
CN108310000A (zh) | 2009-09-10 | 2018-07-24 | 森普拉制药公司 | 治疗疟疾、结核病和mac疾病的方法 |
EP3009442B1 (en) | 2010-03-22 | 2019-06-19 | Cempra Pharmaceuticals, Inc. | Crystalline forms of a macrolide, and uses therefor |
DK2571506T3 (en) | 2010-05-20 | 2017-08-28 | Cempra Pharmaceuticals Inc | PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES |
US9815863B2 (en) | 2010-09-10 | 2017-11-14 | Cempra Pharmaceuticals, Inc. | Hydrogen bond forming fluoro ketolides for treating diseases |
CN103130852B (zh) * | 2011-11-25 | 2016-03-16 | 上海医药工业研究院 | 一种红霉素a衍生物、其制备方法、中间体及应用 |
RU2658050C2 (ru) | 2012-03-27 | 2018-06-19 | Семпра Фармасьютикалз, Инк. | Парентеральные составы для введения макролидных антибиотиков |
JP6426696B2 (ja) | 2013-03-14 | 2018-11-21 | センプラ ファーマシューティカルズ,インコーポレイテッド | 呼吸器疾患の治療のための方法および製剤 |
CA2907085A1 (en) | 2013-03-15 | 2014-09-18 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
CN106457160B (zh) | 2014-05-14 | 2019-10-08 | 陶氏环球技术有限责任公司 | 用亚硝酸后处理的复合聚酰胺膜 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3923784A (en) * | 1973-09-10 | 1975-12-02 | Hoffmann La Roche | Erythromycin a derivatives |
YU35363B (en) * | 1974-01-14 | 1980-12-31 | Pliva Zagreb | Process for obtaining n-(benzene-sulfonyl)-5-0desosaminyl-erythromycilamine derivatives |
PL136968B1 (en) * | 1983-02-10 | 1986-04-30 | Tarchominskie Zaklad Farma | Process for preparing cyclic 11,12-carbonate of erythromycin a |
JPS61103890A (ja) * | 1984-10-26 | 1986-05-22 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシンa誘導体 |
GB8506380D0 (en) * | 1985-03-12 | 1985-04-11 | Beecham Group Plc | Chemical compounds |
US4670549A (en) * | 1985-03-18 | 1987-06-02 | Taisho Pharmaceutical Co., Ltd. | Method for selective methylation of erythromycin a derivatives |
GB8521402D0 (en) * | 1985-08-28 | 1985-10-02 | Beecham Group Plc | Chemical compounds |
DE3782994T2 (de) * | 1986-09-18 | 1993-04-08 | Taisho Pharmaceutical Co Ltd | Erythromycin-a-derivate und verfahren zu ihrer herstellung. |
KR880009960A (ko) * | 1987-02-24 | 1988-10-06 | 데이빗 로버츠 | 화학적 화합물 |
US4857641A (en) * | 1987-08-14 | 1989-08-15 | Pfizer Inc. | C.12 modified erythromycin A derivatives |
IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
-
1991
- 1991-11-07 IL IL99995A patent/IL99995A/xx not_active IP Right Cessation
- 1991-11-07 IL IL11458991A patent/IL114589A/en not_active IP Right Cessation
- 1991-11-19 MA MA22627A patent/MA22344A1/fr unknown
- 1991-11-20 KR KR1019910020684A patent/KR100189597B1/ko not_active IP Right Cessation
- 1991-11-20 DK DK91403119.0T patent/DK0487411T3/da active
- 1991-11-20 ES ES91403119T patent/ES2082952T3/es not_active Expired - Lifetime
- 1991-11-20 IE IE402991A patent/IE74713B1/en not_active IP Right Cessation
- 1991-11-20 CA CA002055912A patent/CA2055912C/fr not_active Expired - Lifetime
- 1991-11-20 FI FI915469A patent/FI102281B/fi not_active IP Right Cessation
- 1991-11-20 EP EP91403119A patent/EP0487411B1/fr not_active Expired - Lifetime
- 1991-11-20 PL PL91306130A patent/PL169422B1/pl not_active IP Right Cessation
- 1991-11-20 AT AT91403119T patent/ATE133683T1/de not_active IP Right Cessation
- 1991-11-20 RU SU915010516A patent/RU2100367C1/ru not_active IP Right Cessation
- 1991-11-20 HU HU622/91A patent/HU218787B/hu not_active IP Right Cessation
- 1991-11-20 SK SK3508-91A patent/SK281550B6/sk unknown
- 1991-11-20 DE DE69116815T patent/DE69116815T2/de not_active Expired - Lifetime
- 1991-11-20 PL PL91292455A patent/PL167448B1/pl not_active IP Right Cessation
- 1991-11-20 CZ CS19913508A patent/CZ290651B6/cs not_active IP Right Cessation
- 1991-11-20 AU AU87986/91A patent/AU640290B2/en not_active Expired
- 1991-11-21 NZ NZ240684A patent/NZ240684A/en unknown
- 1991-11-21 CN CN91111875A patent/CN1033974C/zh not_active Expired - Lifetime
- 1991-11-21 JP JP03331561A patent/JP3130097B2/ja not_active Expired - Lifetime
- 1991-11-21 MX MX9102159A patent/MX9102159A/es unknown
- 1991-11-21 OA OA60098A patent/OA09523A/fr unknown
- 1991-11-21 PT PT99569A patent/PT99569B/pt not_active IP Right Cessation
- 1991-11-21 BR BR919105062A patent/BR9105062A/pt not_active Application Discontinuation
-
1993
- 1993-06-28 US US08/083,636 patent/US5444051A/en not_active Expired - Lifetime
-
1994
- 1994-03-31 US US08/220,484 patent/US5561118A/en not_active Expired - Lifetime
-
1995
- 1995-01-25 US US08/378,186 patent/US5770579A/en not_active Expired - Lifetime
- 1995-07-14 IL IL11458995A patent/IL114589A0/xx unknown
-
1996
- 1996-02-01 GR GR950401767T patent/GR3018848T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT99569A (pt) | Processo para a preparacao de novos derivados de eritromicina e de composicoes farmaceuticas que os contem | |
PT99445A (pt) | Processo para preparacao de derivados do 1,4,7,10-tetraazaciclododecano mono-n--substituidos e de composicoes farmaceuticas que os contem | |
ES2123039T3 (es) | Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ES2081187T3 (es) | Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ES2128519T3 (es) | Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ATE150466T1 (de) | Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon | |
ES2111871T3 (es) | Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
PT97286A (pt) | Processo para a preparacao de novos derivados do 3-aminocromano e de composicoes farmaceuticas que os contem | |
MX9400165A (es) | Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen. | |
PT93915A (pt) | Processo para a preparacao de novos derivados de 4-fenil-metil-1h-indol e de composicoes farmaceuticas que os contem | |
NO903291L (no) | Renin-hemmende aminooligohydroksyderivater. | |
ES2033246T3 (es) | Tioeteres, procedimiento para su preparacion, asi como medicamentos que contienen estos compuestos. | |
DE3764701D1 (de) | N-((trimethoxy-2,4,6-benzoyl)-3-propyl)piperidin-derivate, verfahren zu ihrer herstellung und deren anwendung als heilmittel. | |
ES2103553T3 (es) | Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2091670T3 (es) | Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
NO961657D0 (no) | Dibenz[b,eÅoksepinderivater, fremgangsmåte for fremstilling samt legemiddel inneholdende slike | |
ES2105569T3 (es) | Nuevos analogos de metabolitos de acidos grasos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
PT97255A (pt) | Processo para a preparacao de 3-tia-alquil-flavonas e de 3-oxa-alquil flavonas e substituidas e de composicoes farmaceuticas que as contem | |
MX9204659A (es) | Nuevas 3-(tetrazolil substituido)-oxo-4h-pirido-(1,2-a)-pirimidinas, sales de los mismos, las composiciones farmaceuticas que contienen a los mismos y procedimientos para prepararlas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19920601 |
|
FG3A | Patent granted, date of granting |
Effective date: 19990129 |
|
PC3A | Transfer or assignment |
Free format text: 19991011 HOECHST MARION ROUSSEL FR |
|
PD3A | Change of proprietorship |
Owner name: ROUSSEL UCLAF Effective date: 19991011 |
|
TE3A | Change of address (patent) |
Owner name: ROUSSEL UCLAF Effective date: 19991011 |
|
PC3A | Transfer or assignment |
Free format text: AVENTIS PHARMA S.A. FR Effective date: 20030110 |
|
MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20140129 |